Bill T. Ameredes, PhD
Associate Professor, Division of Pulmonary Critical Care & Sleep Medicine
Bill T. Ameredes, PhD
Associate Professor of Medicine
Associate Professor of Preventive Medicine and Community Health
Associate Professor of Biochemistry and Molecular Biology
William C. Levin Chair, Environmental Toxicology
Associate Director, Coordination Key Resource, NIH CTSA
Director, Environmental Inhalation Exposure Facility
Director, NIEHS Environmental Toxicology Training Program
Distinguished Teaching Professor, Academy of Master Teachers
University of Texas Medical Branch
Division of Pulmonary, and Critical Care Medicine
Medical Research Building 8.104
301 University Blvd.
Galveston, TX 77555-1083
|Degree/Training Completed||Year||Name & Location|
|Ph.D.||1989||Ohio State University, Columbus, Ohio|
|Post-Doctoral Training||1990||University of Florida, Gainesville, FL|
|Post-Doctoral Fellowship||1992||University of Florida, Gainesville, FL|
- Airway smooth muscle biology and beta-receptor regulation
- Immune/inflammatory cytokine responses of the airway
- Beta-agonist regulation of MAPK mechanisms
- Role of carbon monoxide in airway inflammation
- Role of nitric oxide in airway inflammation
- Ameredes, BT. Beta-2-receptor regulation of immunomodulatory proteins in airway smooth muscle. Frontiers in Bioscience (Schol Ed). 3:643-54, 2011.
- Ameredes, BT. Translating airway biomarker information into practice: from theoretical science to applied medicine. Pulm Pharmacol Ther. Sep 30. [Epub ahead of print] 2010.
- Ameredes BT, Sethi JM, Liu H, Choi AMK, Calhoun WJ: Enhanced nitric oxide production associated with airway hyporesponsiveness in the absence of IL-10. Am. J. Physiol. Lung Cell Mol. Physiol. 288:L868-L873, 2005.
- Ameredes BT, Calhoun WJ: Modulation of GM-CSF by enantiomeric beta-agonists in human airway smooth muscle. J. Allergy Clin. Immunol. 116(1):65-72, 2005.
- Ameredes BT: Cardiac activity during airway resistance alterations with intravenous and inhaled methacholine. Respir. Physiol. Neurobiol. 139(3):281-292, 2004.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
- 111 - Stroke Alert
- 112 - Stroke Activation
- 300086 - Stroke Floor Admission
- 3000000001 - Stroke Critical care without tPA
- 300088 Stroke - Transfer from Critical care to floor
- 3004002 - Stroke Discharge
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.